Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2024-03-22 00:00:00 ET · period of report 2024-03-21 · accession 0001415889-24-008956 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-22 | 2024-03-21 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $236.45 | -6,000 | 41.6K | -13% | -$1.42M |
| D | 2024-03-22 | 2024-03-21 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.7K | +16% | +$706.6K |
| D | 2024-03-22 | 2024-03-21 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -6,000 | 54.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-21 | S | D | 1,400 | $237.36 | 36,710 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $237.22 to $237.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-03-21 | S | D | 3,505 | $236.71 | 38,110 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $236.20 to $237.195. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-03-21 | M | A | 6,000 | $117.76 | 42,710 | D | — | — | (F2) Includes 118 shares acquired on March 4, 2024, under the United Therapeutics Corporation Employee Stock Purchase Plan. |
| 4 | Common | Common Stock | 2024-03-21 | S | D | 857 | $234.11 | 41,853 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $233.74 to $234.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2024-03-21 | S | D | 238 | $235.73 | 41,615 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $235.16 to $236.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Derivative | Stock Options | 2024-03-21 | M | D | 6,000 | $0.00 | 54,000 | D | $117.76 · 2021-03-15 to 2027-03-15 | 6,000 Common Stock |